glp-1 semaglutide weight loss treatments orem for Medical in Southampton, PA Another Weight-Loss Trial Win for

Wegovy is a glucagon-like peptide-1 receptor agonist (also known as GLP-1 receptor agonist or GLP-1 RA), which bagged US Food and Drug Administrations approval as a treatment for obesity in June 2021

As GLP-1 therapies continue to evolve, your guidance, education and programming will be key in helping clients translate short-term changes into long-term health

As a DTC telehealth player, you have to be involved in the market even if the GLP-1 boost functions as a short-term cash grab

The current clinical literature does not flag the Ozempic and Lexapro combination as a meaningful serotonin syndrome risk

Table of Contents What Are GLP-1 Injections and How Do They Work